In this study, we have identified VSIG4, a multifaceted checkpoint protein of recent interest in fields of inflammatory disease and cancer, as a novel biomarker of aging Mφ in tissues associated with age‐related systemic inflammation and immunosenescence. Here, VSIG4 is linked to cancer.